This is a preview of subscription content, log in via an institution to check access.
Reference
van Linschoten RCA, et al. Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Alimentary Pharmacology and Therapeutics : 11 Jun 2021. Available from: URL: http://doi.org/10.1111/apt.16445
Rights and permissions
About this article
Cite this article
Cost of inflammatory bowel disease is increasing due to cost of biologicals. PharmacoEcon Outcomes News 881, 7 (2021). https://doi.org/10.1007/s40274-021-7803-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7803-z